Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

59results about How to "Does not affect vitality" patented technology

Method for producing paper pulp by adopting cotton stalk peel as raw material

The invention relates to a method for producing paper pulp by adopting cotton stalk peel as raw material, which adopts an enzyme-ammonium sulfite method. The enzyme-ammonium sulfite method comprises the steps of: firstly, removing pectin of the cotton stalk peel and degrading lignin by using degumming enzyme and then, preparing coarse pulp by an ammonium sulfite boiling step, and finally processing the coarse pulp by a conventional production method to obtain finished product pulp, wherein the degumming enzyme is prepared by compounding pectinase, laccase and lignin enzyme in the weight ratio of 1-3:1:1, and a degumming enzym solution is prepared by compounding the degumming enzyme, urea and water in the weight ratio of 5:5:1000-15:15:1000; the cotton stalk peel is soaked in the sealed degumming enzyme solution for 24-48 hours in the static state at the temperature of 20-30 DEG C. The weight ratio of the ammonium sulfite to the oven dry cotton stalk peel in a boiling solution is 10-13 percent, and the pH value of the boiling solution is 7-9. In the invention, the pectinase is added in the degumming enzyme, which effectively remove pectic substances and solves the problem that subsequent processing is influenced by the existence of the pectin and industrialized production can not be realized. The invention can produce the paper pulp meeting standards. Compared with the traditional chemical pulp producing method, the invention has the advantages of high pulp yield, energy saving, cost reduction and recycled black liquor.
Owner:凌受明

TAT (Trans-activating factor) kringle domain-modified nenurogenin2 fusion protein, as well as preparation method thereof and application thereof

The invention provides a TAT (trans-activating factor) kringle domain-modified nerve transcription factor nenurogenin2 fusion protein, as well as a preparation method and application thereof. Specifically, the fusion protein TAT-nenurogenin2 formed by the nerve transcription factor nenurogenin2 is modified by the protein transduction kringle domain of the human immunodeficiency virus trans-form activation transduction protein TAT. The preparation of the fusion protein provided by the invention comprises the following steps of: (1) selecting a TAT protein transduction domain-containing pTAT-HA expression vector; (2) synthesizing the nerve transcription factor nenurogenin2 target gene segment optimized by prokaryotic expression; (3) connecting T4 ligase with the enzyme-digested product to obtain a pTAT-nenurogenin2 recombinant expression plasmid vector by means of cloning and screening; and (4) transforming the recombinant expression plasmid vector into colon bacillus DE3 competent cell, and inducing protein expression. According to the invention, a large number of TAT-nenurogenin2 fusion protein which is low in cost, high in activity, and capable of inducing the astrocyte to be transformed into the nerve cell with biological activity can be firstly prepared, and the TAT-nenurogenin2 is easy to penetrate through the blood brain barrier (BBB), so that the TAT kringle domain-modified nenurogenin2 fusion protein is wide in the prospect in the clinical treatment of the brain injury disease.
Owner:XIAN MEDICAL UNIV

TAT protein transduction modified NEP1-40 fusion protein and use thereof

InactiveCN101418046APreserve penetrationSolve the problem of not being able to cross the blood-brain barrier (BBB)Nervous disorderPeptide/protein ingredientsNervous systemHigh activity
The invention discloses a preparation method for TAT-NEP1-40 fusion protein and application in treating the injuries of a central nervous system, CNS. The TAT-NEP1-40 fusion protein is characterized in that the TAT-NEP1-40 fusion protein comprises the protein transduction domain (PTD) of a transactivating transduction protein TAT of the human immunodeficiency virus (HIV) and Nogo extracellular peptide residues 1-40, NEP1-40. The fusion protein retains the selective antagonistic activity of the NEP1-40 to a Nogo receptor, NgR, and has the advantages of high transduction efficiency and easy penetration of BBB and BCSB, thereby overcoming the limitation of the NEP1-40, avoiding the extra injuries on nervous tissues caused by the mode of injecting the NEP1-40 through microinjection or miniature pump implantation, and overcoming the problem that the NEP1-40 can hardly pass BBB and BCSB to reach corresponding biological concentration. The fusion protein can be prepared in a large quantity, has a low cost and high activity, and can be used for treating a plurality of CNS injuries including cerebral ischemia, cerebral anoxia, cerebral hemorrhage, cerebral trauma, spinal core injury, and the like, and promoting the regeneration and functional rehabilitation of nervous tissues.
Owner:FOURTH MILITARY MEDICAL UNIVERSITY

Post-harvest treatment and storage method for potato minituber produced by fog culture method

The invention discloses a post-harvest treatment and storage method for a potato minituber produced by a fog culture method, relates to the post-harvest treatment and storage method for the potato minituber and requirements of the potato minituber on an environment during treatment and storage, and mainly solves the problem of difficulty in storage of the potato minituber produced by a fog culture technology or a water culture technology. The post-harvest treatment and storage method comprises the following steps: after harvesting a tuber, timely killing various pathogens on the surface of the tuber, and creating proper environmental conditions for quickly healing wounds on the surface of the tuber, quickly suberifying epidermis, increasing solanine content and laying a foundation for improving resistance to pest and disease damage during storage, keeping freshness and vitality of the minituber and greatly prolonging the storage period; and storing the treated minituber for a long time in a low-temperature high-humidity storage facility. Compared with the conventional storage method, the post-harvest treatment and storage method has the advantages as follows: pest and disease damage is basically not caused during storage, the storage period of the tuber is greatly prolonged to be about 18 months, the water loss of the tuber is very low, and the freshness and the vitality of the minituber are maintained.
Owner:YUNNAN AGRICULTURAL UNIVERSITY

Application of leonurine in preparation of medicine for improving infertility pregnancy outcome

The invention belongs to the field of modern pharmacy of traditional Chinese medicines, and relates to application of a specific monomer leonurine in preparation of a medicine for improving infertility pregnancy outcome. The leonurine is injected into the abdominal cavity during an EMS (acute renal syndrome) modeling period, so that the volume and weight of an ectopic focus can be remarkably reduced, local fibrosis, invasion and transfer are inhibited, and the pregnancy rate of an EMS model mouse can be remarkably increased. The leonurine inhibits proliferation and invasion of endometrium stromal cells by inducing apoptosis of the endometrium stromal cells, adjusts expression balance of a local estrogen-progestin receptor of the ectopic focus, activates EMS model pelvic and abdominal immune cells, enhances phagocytic and killing functions of the cells, reverses poor ecdysis of the EMS model mouse, has similar effects on growth and invasion of ectopic focus ESC of a human EMS patient and expression of the estrogen-progestin receptor, does not affect growth and activity of the endometrium ESC of a normal child-bearing female, hormone receptor expression, ecdysis process and proliferation, apoptosis and cell activity of human early-pregnancy embryo trophoblast, and can be used for preparing an effective prevention and treatment medicine for EMS combined infertility patients.
Owner:THE OBSTETRICS & GYNECOLOGY HOSPITAL OF FUDAN UNIV

Breeding box

The invention discloses a breeding box. The breeding box is characterized in that the breeding box comprises a first classification box, a second classification box and a third classification box which are in sequential suit installation from top to down; the volume of the three classification boxes increases in turn, and openings are opened on the upper ends of all the three classification boxes; the opening of the second classification box is set to be adapted to the size of the bottom of the first classification box; the opening of the third classification box is set to be adapted to the size of the bottom of the second classification box; the first classification box extends out from the opening of the second classification box to be fixedly mounted in the second classification box; afirst fish barrel horizontally running through the second classification box is disposed on the bottom end of the side wall of the first classification box; both sides of the upper ends of both the second classification box and the third classification box are provided with hinged sealing cover plates; only a valve body needs opening to let out all water when breeding is completed and fish need taking out; to remove the fish from the three boxes in an orderly manner, only the sealing cover plates need opening, and thus, the breeding box is easy to use.
Owner:句容市南湖有机农业发展有限公司

Propagule extract and application thereof

The invention discloses a propagule (including individual, organ, tissue, cell and other biological sexual, asexual and parthenogenetic propagation materials, maternal, young, ovum and germ cells, and animal tissue, cell, spore, hypha, sporocarp and other sexual or asexual propagation fungus materials for division reproduction, germination reproduction, rupture reproduction and the like) extract and an application thereof. The propagule extract is obtained by extracting a required propagule; when in use, the extract is uniformly mixed with a solvent to prepare a dormancy period prolonging agent. The surface of the propagule can be covered with a storage life prolonging agent to form a film by means of spraying, soaking, brushing and the like, the treated propagule can be stored by means of packaging, sustained-release microcapsules and the like after being aired, or the storage life prolonging agent is combined with other storage methods to prolong the dormancy period. According to the propagule (including the individual, the organ, the tissue, the cell and the other biological sexual, asexual and parthenogenetic propagation materials, the maternal, the young, the ovum and the germ cells, and the animal tissue, the cell, the spore, the hypha, the sporocarp and the other sexual or asexual propagation fungus materials for division reproduction, germination reproduction, rupture reproduction and the like) extract and the application thereof, The dormancy period of the propagule can be obviously prolonged, the reproductive capacity of the propagule subjected to activating treatment is recovered, and the development of the subsequent propagule is not influenced.
Owner:沈阳恩柽研究院有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products